2026-08-10T12:39:50-05:00 2025-12-31 410746749 CLIFTONLARSONALLEN LLP 220 S 6TH STREET SUITE 300 MINNEAPOLIS MN 55402 990 2025-01-01 411717098 AMERICAN BRAIN FOUNDATION AMER 8667707570 2909 WAYZATA BLVD 62124 MINNEAPOLIS MN 55405 MICHELLE HERITAGE EXECUTIVE DIRECTOR 8667707570 2026-08-07 1 SARAH REICHLING P01587996 6123764500 2026-08-07 2025 2025-03-06 01:10:19Z X MICHELLE HERITAGE 2909 WAYZATA BLVD 62124 MINNEAPOLIS MN 55405 10698310 0 X HTTPS://WWW.AMERICANBRAINFOUNDATION.ORG/ X 1992 MN TO ACCELERATE BREAKTHROUGH RESEARCH ON BRAIN DISEASE AND OPTIMIZE BRAIN HEALTH FOR ALL. ABF FUNDS THE BEST AND BRIGHTEST SCIENTISTS TO MAKE A LASTING IMPACT ON PUBLIC HEALTH AND OUR COLLECTIVE KNOWLEDGE OF THE BRAIN. 17 17 15 48 0 0 5775187 7608054 0 0 512199 654254 -47358 -418773 6240028 7843535 2384275 8135005 0 0 1563823 1923644 18000 0 1266357 1288705 966375 5254803 11025024 985225 -3181489 21621469 22081098 1396515 3763500 20224954 18317598 THE AMERICAN BRAIN FOUNDATION ACCELERATES BREAKTHROUGH RESEARCH ACROSS BRAIN DISEASES AND DISORDERS BY INVESTING IN INNOVATIVE SCIENCE, EARLY-CAREER INVESTIGATORS, AND CROSS-DISEASE DISCOVERIES THAT ADVANCE TREATMENTS, CURES, AND BRAIN HEALTH FOR ALL. 0 0 889892 0 0 THE FOUNDATION ADVANCED PUBLIC UNDERSTANDING OF BRAIN RESEARCH AND BRAIN HEALTH THROUGH EDUCATIONAL CONTENT, RESEARCH UPDATES, PATIENT AND CAREGIVER STORIES, PUBLIC EVENTS, AND DONOR ENGAGEMENT. THESE EFFORTS HELPED PEOPLE SEE THE CONNECTIONS AMONG BRAIN DISEASES, REDUCE STIGMA, AND UNDERSTAND THE URGENCY AND PROMISE OF RESEARCH. THROUGH ITS CURE ONE, CURE MANY APPROACH, THE FOUNDATION SHOWED HOW DISCOVERIES IN ONE BRAIN DISEASE CAN ACCELERATE PROGRESS ACROSS MANY, INSPIRING AWARENESS, ADVOCACY, AND PHILANTHROPIC SUPPORT. 8135005 8135005 0 IN 2025, THE FOUNDATION INVESTED IN RESEARCH ACROSS MULTIPLE BRAIN DISEASES THROUGH ITS NEXT GENERATION RESEARCH GRANTS AND CURE ONE, CURE MANY INITIATIVES. IT FUNDED EARLY-CAREER INVESTIGATORS AND INNOVATIVE PROJECTS IN ALS, ALD, ALZHEIMER'S AND AGE-RELATED COGNITIVE DECLINE, EPILEPSY, FRONTOTEMPORAL DEGENERATION, LEWY BODY DISEASES, MULTIPLE SCLEROSIS, NEUROMUSCULAR DISEASE, NEUROLOGICAL HEALTH DISPARITIES, PARKINSON'S DISEASE, PERIPHERAL NEUROPATHY, AND STROKE. THESE GRANTS HELP LAUNCH RESEARCH CAREERS; MORE THAN 95% OF NEARLY 330 FOUNDATION-FUNDED INVESTIGATORS HAVE SECURED FOLLOW-ON SUPPORT FROM NIH OR OTHER MAJOR FUNDERS. THE FOUNDATION ALSO ADVANCED TWO CROSS-DISEASE INITIATIVES TO TARGET SHARED MECHANISMS AND ACCELERATE DISCOVERIES FOR PATIENTS. 9024897 1 1 0 0 0 1 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 19 0 1 15 1 0 0 0 0 0 0 0 0 0 0 0 0 X 17 17 0 0 1 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AK AL AR CA CO CT DC FL GA HI IL KS KY MA MD ME MI MN MO MS NC ND NH NJ NM NV NY OH OK OR PA RI SC TN UT VA WA WI WV X X SETH MADDOX 6512897660 1715 YANKEE DOODLE RD STE 305 EAGAN MN 55121 MICHELLE HERITAGE EXECUTIVE DIRECTOR 40.00 X 365800 0 34275 HEATHER HEART DEPUTY DIRECTOR 40.00 X 170000 0 0 JULIA MIGLETS-NELSON DIRECTOR, RESEARCH PROGRAMS & PARTNERSHIPS 40.00 X 131435 0 11740 KIMBERLY HOWARD DIRECTOR OF OPERATIONS 40.00 X 128000 0 462 SEAN SANSIVERI CHAIR 1.50 X X 0 0 0 BEN LENAIL VICE CHAIR 1.00 X X 0 0 0 ALYX B PORTER UMPHREY SECRETARY 1.00 X X 0 0 0 RALPH R LESLIE TREASURER 1.00 X X 0 0 0 PHYLLIS C ZEE EX OFFICIO VOTING DIRECTOR 0.50 X X 0 0 0 PAUL J CAIRNS DIRECTOR 0.50 X 0 0 0 MERIT CUDKOWICZ DIRECTOR 0.50 X 0 0 0 DAVID W DODICK DIRECTOR 0.50 X 0 0 0 CHRISTINA M FRANCIS DIRECTOR 0.50 X 0 0 0 JACQUELINE FRENCH DIRECTOR 0.50 X 0 0 0 FRANCES JENSEN DIRECTOR 0.50 X 0 0 0 BRUCE KAHNE DIRECTOR 0.50 X 0 0 0 THABELE LESLIE-MAZWI DIRECTOR 0.50 X 0 0 0 MATTHEW S PICARD DIRECTOR 0.50 X 0 0 0 ALFREDO QUIONES-HINOJOSA DIRECTOR 0.50 X 0 0 0 RICHARD RANSOHOFF DIRECTOR 0.50 X 0 0 0 JOANNE L SMIKLE DIRECTOR 0.50 X 0 0 0 795235 0 46477 4 0 1 0 ALL IN ONE ACCOUNTING 1715 YANKEE DOODLE RD SUITE 305 EAGAN MN 55121 ACCOUNTING 114685 1 1181398 6426656 22925 7608054 638380 638380 2395989 2380115 15874 15874 15874 49102 1181398 474660 -425558 -425558 MISCELLANEOUS INCOME 900099 6785 6785 6785 7843535 0 0 235481 8135005 8135005 400075 28005 180034 192036 1151460 494690 52083 604687 150915 51751 21554 77610 115046 48808 5900 60338 106148 36400 15160 54588 153987 153987 37450 19589 6259 11602 27373 14318 4575 8480 74283 74283 17375 9088 2903 5384 201265 106321 33971 60973 90424 14945 40884 34595 99439 4748 10573 84118 160024 50071 88268 21685 12813 12813 BAD DEBT EXPENSE 60158 8324 22773 29061 FUNDRAISING EVENTS 11309 11309 EMPLOYEE DEVELOPMENT 10643 1473 4029 5141 DUES AND SUBSCRIPTIONS 9832 1361 3721 4750 11025024 9024897 733770 1266357 1027870 338455 4083926 3697977 4270938 3847926 84807 11372 40021 54888 186745 186745 0 0 12113907 14130480 21621469 22081098 127764 148911 1268751 3614589 1396515 3763500 X 7431093 9253927 12793861 9063671 20224954 18317598 21621469 22081098 -3181489 1274133 0 X X 0 1 X 1 0 X 6035920 6002262 10120593 5775187 7657156 35591118 6035920 6002262 10120593 5775187 7657156 35591118 9351240 26239878 441373 162383 419135 422198 638380 2083469 2269 46067 6785 55121 37729708 0.69550 0.63990 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 4915589 225000 721926 48468 5814047 4589366 2452 438513 114742 4915589 4128167 4493 581180 124472 4589368 488034 10401 -653510 116757 -271832 4028837 380695 597232 118730 4888034 0.00000 0.55000 0.45000 0 0 186745 186745 0 0 X 9960608 1274133 442563 474660 2191356 7769252 74283 74283 7843535 11867964 442563 474660 917223 10950741 74283 74283 11025024 PART V, LINE 4: THE ENDOWMENT IS USED TO SUPPORT RESEARCH AND AWARDS. PART X, LINE 2: THE ORGANIZATION FOLLOWS THE PROVISIONS OF FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) ASC 740-10-25, WHICH REQUIRES THAT A TAX POSITION BE RECOGNIZED OR DERECOGNIZED BASED ON A MORE LIKELY THAN NOT THRESHOLD. THIS APPLIES TO POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THE ORGANIZATION DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE ANY UNCERTAIN TAX POSITIONS. THE ORGANIZATION'S TAX RETURNS ARE SUBJECT TO REVIEW AND EXAMINATION BY FEDERAL AUTHORITIES. PART XI, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 474,660. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 474,660. COMMITMENT TO CURES 210588 178735 31853 96781 1200 34755 NASHVILLE FUNDRAISING EVENT 1019912 1002663 17249 9800 332124 1230500 1181398 49102 9800 96781 1200 366879 474660 -425558 1 AMERICAN ACADEMY OF NEUROLOGY INSITUTE 201 CHICAGO AVENUE MINNEAPOLIS MN 55415 410726167 501(C)(3) 8076423 0 CLINICAL RESEARCH TRAINING SCHOLARSHIPS, SCIENTIFIC AWARDS, AND NON SCIENTIFIC AWARDS FOR WORK ON DISEASES OF THE BRAIN AND NERVOUS SYSTEM. NATIONAL MULTIPLE SCLEROSIS SOCIETY 900 S BROADWAY DENVER CO 80209 135661935 501(C)(3) 25000 0 PROGRAM SUPPORT SOCIETY FOR NEUROSCIENCE 1121 14TH STREET NW SUITE 1010 WASHINGTON DC 20006 520895843 501(C)(3) 25000 0 PROGRAM SUPPORT 3 0 PART I, LINE 2: THE AMERICAN BRAIN FOUNDATION'S (ABF) NEXT GENERATION RESEARCH GRANTS PROGRAM FUNDS CLINICAL RESEARCH TRAINING SCHOLARSHIPS (CRTS) AND CLINICIAN SCIENTIST DEVELOPMENT AWARDS (CSDA) OFFERED TO NEUROLOGISTS AND CLINICAL INVESTIGATORS INTERESTED IN ACADEMIC CAREERS IN CLINICAL RESEARCH ON BRAIN DISEASES AND DISORDERS. MORE THAN 80 PERCENT OF THE RECIPIENTS OF THESE ABF-FUNDED AWARDS HAVE GONE ON TO RECEIVE FUNDING FROM NIH, ENABLING A LIFETIME OF RESEARCH ON BRAIN DISEASE. THE ABF AWARDS GRANT FUNDING TO THE RESEARCH PROGRAMS OF THE AMERICAN ACADEMY OF NEUROLOGY, THE NATIONAL MULTIPLE SCLEROSIS SOCIETY, AND OTHER INSTITUTIONS WHO REGRANT FUNDS TO EARLY CAREER INVESTIGATORS THROUGH THEIR INSTITUTIONS. THE ADMINISTERING INSTITUTIONS REPORT PROGRESS ANNUALLY BACK TO THE ABF. X X X X 0 0 0 0 0 0 0 0 0 MICHELLE HERITAGE EXECUTIVE DIRECTOR 325500 0 40300 0 0 0 34275 0 0 0 400075 0 0 0 HEATHER HEART DEPUTY DIRECTOR 168000 0 2000 0 0 0 0 0 0 0 170000 0 0 0 FORM 990, PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE SHALL INCLUDE THE CHAIR, VICE-CHAIR, SECRETARY, TREASURER, AND NO MORE THAN THREE OTHER MEMBERS OF THE BOARD AS APPOINTED BY THE CHAIR. THE CHAIR OF THE BOARD SHALL BE THE CHAIR OF THE EXECUTIVE COMMITTEE. MEETINGS MAY BE CONDUCTED BY GROUP MEETINGS, CONFERENCE CALL, OR OTHER ELECTRONIC MEANS OF COMMUNICATION. BETWEEN MEETINGS OF THE BOARD, THE BOARD'S POWER IS DELEGATED TO THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL REPORT ITS ACTIVITY TO THE BOARD. FORM 990, PART VI, SECTION A, LINE 4 THE ORGANIZATION NO LONGER HAS ANY ASSOCIATION WITH AMERICAN ACADEMY OF NEUROLOGY ("AAN"). FORM 990, PART VI, SECTION B, LINE 11B THIS FORM 990 WAS PRESENTED TO THE FINANCE/AUDIT COMMITTEE BY THE CFO AND THE EXECUTIVE DIRECTOR. THE FINANCE/AUDIT COMMITTEE REVIEWED THE FORM 990 AND IDENTIFIED AND AGREED UPON CHANGES TO BE MADE. IN LINE WITH MINNESOTA LAW, THE FINAL FORM 990 IS PRESENTED TO AND APPROVED BY THE BOARD OF DIRECTORS. THE FORM 990 IS FILED SUBSEQUENT TO THIS PROCESS. FORM 990, PART VI, SECTION B, LINE 12C THE FOUNDATION'S CONFLICT OF INTEREST POLICY COVERS INDIVIDUALS SERVING AS AN OFFICER, DIRECTOR, COMMITTEE MEMBER, OR POSITIONS OF OFFICIAL RESPONSIBILITY OR LEADERSHIP. ALL COVERED ARE REQUIRED TO COMPLETE A RELATIONSHIP DISCLOSURE STATEMENT ANNUALLY, OR AS CHANGED IN PERSONAL CIRCUMSTANCES OCCUR. THE STATEMENTS ARE REVIEWED AND ACTIONS DETERMINED ACCORDING TO THE FOUNDATION'S HIERARCHY BASED ON POSITION OR BY THE EXECUTIVE COMMITTEE IF A RESOLUTION CANNOT BE MADE. POTENTIAL CONFLICTS ARE HANDLED ON AN INDIVIDUAL BASIS. ACTIONS TAKEN DEPEND ON THE SEVERITY OF THE CONFLICT WHICH INCLUDE NO ACTION REQUIRED, ON-GOING MONITORING WITH APPROPRIATE DISCLOSURE OR WITHDRAWAL FROM THE CONFLICTING RELATIONSHIP. CONFLICT OF INTEREST PROCEEDING ARE DOCUMENTED IN MEETING MINUTES OR AS APPROPRIATE FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE DIRECTORS COMPENSATION IS REVIEWED AND APPROVED BY THE ABF EXECUTIVE COMMITTEE, THERE WAS NO INCREASE IN 2025. THE PROCESS WOULD TYPICALLY INCLUDE OUR OUTSOURCED HR ORGANIZATION PROVIDING COMPARABLE DATA OF SIMILAR ORGANIZATION'S AND OTHER SUPPORTING DOCUMENTS TO PROVIDE TO THE ABF EXECUTIVE COMMITTEE. KEY EMPLOYEES COMPENSATION IS DETERMINED BY MICHELLE HERITAGE AND IT IS TYPICALLY THE STANDARD COLA INCREASE. IF THERE IS A MARKET ADJUSTMENT OR A PROMOTION THEN THE DATA IS COLLECTED AND PROVIDED TO THE EXECUTIVE DIRECTOR BY OUR OUTSOURCED HR ORGANIZATION TO SUGGEST/SUPPORT THOSE ADJUSTMENTS. THE PROCESS DESCRIBED HERE WAS LAST COMPLETED IN 2025. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION MAKES THE MOST RECENT THREE YEARS AUDITED FINANCIAL STATEMENTS AND IRS FORM 990 AVAILABLE TO THE PUBLIC ON ITS WEBSITE. THE FOUNDATION DOES NOT MAKE ITS OTHER GOVERNING DOCUMENTS (E.G. ARTICLES OF INCORPORATION) NOR ITS CONFLICT OF INTEREST POLICY AVAILABLE TO THE PUBLIC. FORM 990, PART XII, LINE 2C: THE PROCESS FOR OVERSIGHT AND SELECTION OF AN INDEPENDENT ACCOUNTANT HAS NOT CHANGED FROM THE PRIOR YEAR.